Chang WY, Chiu YC, Chiu FW, Hsu YC, et al. High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy. J Infect Dis 2020 May 12. pii: 5836326. doi: 10.1093.
PMID: 32396638